Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Resistant MS Spasticity Treatment with Sativex and Driving

Trial Profile

Resistant MS Spasticity Treatment with Sativex and Driving

Phase of Trial: Phase IV

Latest Information Update: 29 Aug 2017

At a glance

  • Drugs Nabiximols (Primary)
  • Indications Muscle spasticity
  • Focus Pharmacodynamics
  • Sponsors Almirall S.A.
  • Most Recent Events

    • 28 Apr 2014 Status changed from active, no longer recruiting to completed as reported by German Clinical Trials Register.
    • 02 Oct 2013 Results have been presented at the 29th Congress of the European Committee for Treatment and Research in Multiple Sclerosis (ECTRIMS) according to a GW Pharmaceuticals media release.
    • 20 May 2013 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top